StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Investment analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Tuesday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of Ampio Pharmaceuticals stock opened at $0.01 on Tuesday. The business has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $2.47. The stock has a market capitalization of $11,400.00, a P/E ratio of 0.00 and a beta of 3.66.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.